GLP-1 Receptor Agonist Prescriptions for Adolescents With Obesity and Associated Disparities

This study examines the prescribing of glucagon-like peptide-1 receptor agonists for adolescents with obesity and associated disparities.

Corresponding Author: Yuan Lu, ScD, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, Center for Outcomes Research and Evaluation, Yale New Haven Hospital, 195 Church St, 5th Floor, New Haven, CT 06510 (y.lu@yale.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.